Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinic Acid for the Treatment of Alzheimer's Disease
NCT06582706Phase 2Recruiting
- Sponsor
- Indiana University
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niacin in Alzheimer's disease (AD), sponsored by Indiana University. Started Dec 2024; status: recruiting.
02
Drugs
niacin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT06582706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06582706.